Axcella Health Inc.

4.44+0.1900+4.47%Vol 80.85K1Y Perf 26.57%
Apr 19th, 2021 15:03 DELAYED
BID4.38 ASK4.45
Open4.26 Previous Close4.25
Pre-Market- After-Market-
 - -%  - -
Target Price
15.25 
Analyst Rating
Strong Buy 1.00
Potential %
243.47 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-100/-100/33 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-100/-100/65 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/69 
Income Ranking
 —    -
Market Cap167.34M 
Earnings Rating
Sell
Price Range Ratio 52W %
22.04 
Earnings Date
10th May 2021

Today's Price Range

4.104.45

52W Range

3.517.73

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-2.07%
1 Month
-23.70%
3 Months
-25.31%
6 Months
-11.83%
1 Year
26.57%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
AXLA4.440.19004.47
AAPL134.480.32000.24
GOOG2 300.002.24000.10
MSFT258.77-1.9700-0.76
XOM56.31-0.3500-0.62
WFC44.140.30000.68
JNJ162.870.63000.39
FB301.66-4.5200-1.48
GE13.440.05000.37
JPM153.11-0.1900-0.12
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.36-0.40-11.11
Q03 2020-0.38-0.3410.53
Q02 2020-0.52-0.487.69
Q01 2020-0.92-0.6529.35
Q04 2019-0.93-0.6826.88
Q03 2019-0.78-0.753.85
Q02 2019-0.69-0.95-37.68
Q01 2019-0.39-2.43-523.08
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.42-5.00Negative
6/2021 QR-0.430.00-
12/2021 FY-1.814.23Positive
12/2022 FY-2.29-14.50Negative
Next Report Date10th May 2021
Estimated EPS Next Report-0.42
Estimates Count6
EPS Growth Next 5 Years %-
Volume Overview
Volume80.85K
Shares Outstanding37.69M
Trades Count635
Dollar Volume400.95K
Avg. Volume80.35K
Avg. Weekly Volume109.84K
Avg. Monthly Volume86.37K
Avg. Quarterly Volume79.49K

Axcella Health Inc. (NASDAQ: AXLA) stock closed at 4.25 per share at the end of the most recent trading day (a -0.23% change compared to the prior day closing price) with a volume of 102.24K shares and market capitalization of 167.34M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 66 people. Axcella Health Inc. CEO is William R. Hinshaw.

The one-year performance of Axcella Health Inc. stock is 26.57%, while year-to-date (YTD) performance is -18.11%. AXLA stock has a five-year performance of %. Its 52-week range is between 3.51 and 7.73, which gives AXLA stock a 52-week price range ratio of 22.04%

Axcella Health Inc. currently has a PE ratio of -, a price-to-book (PB) ratio of 1.11, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -55.43%, a ROC of -53.60% and a ROE of -83.37%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Axcella Health Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.42 for the next earnings report. Axcella Health Inc.’s next earnings report date is 10th May 2021.

The consensus rating of Wall Street analysts for Axcella Health Inc. is Strong Buy (1), with a target price of $15.25, which is +243.47% compared to the current price. The earnings rating for Axcella Health Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Axcella Health Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Axcella Health Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 16.50, ATR14 : 0.42, CCI20 : -121.29, Chaikin Money Flow : -0.26, MACD : -0.42, Money Flow Index : 27.32, ROC : -8.21, RSI : 39.37, STOCH (14,3) : 21.05, STOCH RSI : 0.39, UO : 37.64, Williams %R : -78.95), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Axcella Health Inc. in the last 12-months were: David R. Epstein (Buy at a value of $475 000), Manu Chakravarthy (Option Excercise at a value of $0), Manu Chakravarthy (Sold 18 472 shares of value $101 631 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Axcella Health Inc.

Axcella Health Inc a biotechnology company involved in the research and development of novel multifactorial interventions to support health and address dysregulated metabolism. Its AXA candidates are generated from its proprietary, human-focused AXA Development Platform and harness the power of endogenous metabolic modulators, or EMMs. The company's pipeline comprises five programs focused on the metabolic functions of the liver, muscle, and blood.

CEO: William R. Hinshaw

Telephone: +1 857 320-2200

Address: 840 Memorial Drive, Cambridge 02139, MA, US

Number of employees: 66

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

68%32%

Bearish Bullish

53%48%

Bearish Bullish

61%39%

News

Stocktwits